Haris Babačić

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: NATURE COMMUNICATIONS. 2023;14(1):5921

Comprehensive proteomics and meta-analysis of COVID-19 host response.

Babačić H; Christ W; Araújo JE; Mermelekas G; Sharma N; Tynell J; García M; Varnaite R; Asgeirsson H; Glans H; Lehtiö J; Gredmark-Russ S; Klingström J; Pernemalm M
Article: RESPIRATORY RESEARCH. 2023;24(1):62

Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia.

Palma Medina LM; Babačić H; Dzidic M; Parke Å; Garcia M; Maleki KT; Unge C; Lourda M; Kvedaraite E; Chen P; Muvva JR; Cornillet M; Emgård J; Moll K; Karolinska K. I./K. COVID-19 Study Group; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg K-J; Sandberg JK; Gredmark-Russ S; Rooyackers O; Svensson M; Chambers BJ; Eriksson LI; Pernemalm M; Björkström NK; Aleman S; Ljunggren H-G; Klingström J; Strålin K; Norrby-Teglund A
Article: MOLECULAR ONCOLOGY. 2023;17(2):238-260

Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.

Babačić H; Galardi S; Umer HM; Hellström M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
Article: NEOPLASIA. 2021;23(8):783-791

Plasma proteome alterations by MAPK inhibitors in BRAFV600-mutated metastatic cutaneous melanoma.

Babačić H; Eriksson H; Pernemalm M
Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2020;8(1):e000204

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma.

Babačić H; Lehtiö J; Pico de Coaña Y; Pernemalm M; Eriksson H
Article: JOURNAL OF NEUROLOGY. 2019;266(6):1358-1366

Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.

Montagnese F; Babačić H; Eichhorn P; Schoser B
Article: JOURNAL OF NEUROLOGY. 2019;266(1):133-147

Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.

Wenninger S; Greckl E; Babačić H; Stahl K; Schoser B
Article: JOURNAL OF NEUROMUSCULAR DISEASES. 2018;5(4):451-459

How to Interpret Abnormal Findings of Spirometry and Manometry in Myotonic Dystrophies?

Babačić H; Goldina O; Stahl K; Montagnese F; Jurinović V; Schoser B; Wenninger S
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2018;25:112-121

The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?

Barin L; Salmen A; Disanto G; Babačić H; Calabrese P; Chan A; Kamm CP; Kesselring J; Kuhle J; Gobbi C; Pot C; Puhan MA; von Wyl V; Swiss Multiple Sclerosis Registry (SMSR)
Article: NEUROMUSCULAR DISORDERS. 2018;28(3):229-235

Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey.

Jiménez-Moreno AC; Raaphorst J; Babačić H; Wood L; van Engelen B; Lochmüller H; Schoser B; Wenninger S

Alla övriga publikationer

Thesis / dissertation: 2023

Discovering circulating protein biomarkers through in-depth plasma proteomics

Babačić, Haris
Preprint: BIORXIV. 2022

Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures

Babačić H; Galardi S; Umer HM; Cardinali D; Pellegatta S; Hellström M; Uhrbom L; Maturi N; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
Letter: ALLERGY. 2022;77(1):296-298

A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals.

Brnjarchevska Blazhevska T; Babačić H; Sibinovska O; Dobrevski B; Kirijas M; Milanovski G; Arsov T; Petlichkovski A
Meeting abstract: ANNALS OF ONCOLOGY. 2020;31:S760

Plasma proteomics in patients with metastatic cutaneous melanoma treated with targeted therapy

Eriksson H; Babacic H; Lehtio J; Pernemalm M
Preprint: MEDRXIV. 2020

Global between-countries variance in SARS-CoV-2 mortality is driven by reported prevalence, age distribution, and case detection rate

Babačić H; Lehtiö J; Pernemalm M
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):9574

Plasma proteomic analyses and treatment predictive biomarker candidates in melanoma patients receiving immune checkpoint blockade or targeted therapy.

Eriksson H; Babacic H; Lehtio J; Pernemalm M
Conference publication: NERVENHEILKUNDE. 2019;38(05):286-287

Diagnostische Relevanz von Myositis-Antikörpern in der neuromuskulären Ambulanz: eine retrospektive Studie

Montagnese F; Babacic H; Eichhorn P; Schoser B
Review: PLOS ONE. 2019;14(2):e0212198

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.

Babačić H; Mehta A; Merkel O; Schoser B
Conference publication: NEUROMUSCULAR DISORDERS. 2018;28:S137

Safety and efficacy of recurrent inspiratory muscle training in late onset Pompe disease

Wenninger S; Greckl E; Babacic H; Schoser B

Anställningar

Postdoktor, Onkologi-Patologi, Karolinska Institutet, 2023-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2023
Master of Science in Epidemiology, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-Universität München, 2017
Doctor of Medicine, Faculty of Medicine, Saints Cyril and Methodius University of Skopje, 2015

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI